Primary immature teratoma of the prostate with angiosarcoma component: its unusual response to chemotherapy.
Here, we present a case of immature teratoma of prostatic origin, which included an angiosarcoma component. This mass proved unresponsive against preoperative chemotherapy for immature teratoma. Angiosarcoma, although quite rare, should be included in the differential diagnosis as a component of prostatic teratoma, especially in cases in which the tumor proves unresponsive to well-known chemotherapeutic protocols. This is, to our knowledge, the first reported case of primary prostatic immature teratoma containing an angiosarcoma component.
Lee
Hyun Moo
HM
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Song
Sang Yong
SY
Park
Joon Oh
JO
Kim
Bo-Hyun
BH
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001707:Biopsy, Needle; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use; D006394:Hemangiosarcoma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009378:Neoplasms, Multiple Primary; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D013724:Teratoma / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin